X

Health Care

Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23

Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR…

Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%

Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by…

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd  (NSE:TORNTPHARM) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Sudhir Menon -- Chief Financial Officer…

SBI LIFE INSURANCE CO LTD (SBILIFE) Q2 FY23 Earnings Concall Transcript

SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Mahesh Kumar Sharma --…

Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript

Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head -…

Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Transcript

Laurus Labs Limited (NSE:LAURUSLABS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Satyanarayana Chava -- Chief Executive Officer V.V. Ravi Kumar -- Chief Financial…

Decoding India’s leading API development company – Dr Reddy’s Laboratories

About Company:  Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company…

Syngene International Ltd (SYNGENE) Q2 FY23 Earnings Concall Transcript

Syngene International Ltd (NSE:SYNGENE) Q2 FY23 Earnings Concall dated  Oct. 20, 2022 Corporate Participants: Avantika Mishra -- Investor Relations` Jonathan…

Granules India Ltd (GRANULES) Q2 FY23 Earnings Concall Transcript

Granules India Ltd (NSE:GRANULES) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate participants: Irfan Raeen -- Investor Relation Dr.…

Eris Lifesciences Ltd (ERIS) Q2 FY23 Earnings Concall Transcript

Eris Lifesciences Ltd (NSE:ERIS) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate Participants: Krishnakumar Vaidyanathan -- Executive Director and…